Kate Rochlin
Chief Operating Officer presso IN8BIO, INC.
Patrimonio netto: 20 718 $ in data 31/03/2024
Profilo
Kate Rochlin is the founder of Immunovent LLC.
She is currently the Executive Director at Solution Lab, Inc. since 2019 and the Chief Operating Officer at IN8bio, Inc. since 2020.
Previously, she worked as the Director-Scientific Affairs at Filament BioSolutions, Inc. and as the Chief Business Officer at Curadigm SAS in 2020.
Dr. Rochlin completed her undergraduate degree at the University of Pennsylvania and obtained her doctorate from Weill Cornell Medical College.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
IN8BIO, INC.
0.04% | 07/02/2024 | 17 558 ( 0.04% ) | 20 718 $ | 31/03/2024 |
Posizioni attive di Kate Rochlin
Società | Posizione | Inizio |
---|---|---|
IN8BIO, INC. | Chief Operating Officer | 01/12/2020 |
Solution Lab, Inc. | Director/Board Member | 01/10/2019 |
Precedenti posizioni note di Kate Rochlin
Società | Posizione | Fine |
---|---|---|
Curadigm SAS | Corporate Officer/Principal | 01/08/2020 |
Immunovent LLC
Immunovent LLC Medical/Nursing ServicesHealth Services Immunovent LLC is a biotech company based in New York, NY. Immunovent is revolutionizing allergy diagnostics by coupling existing clinical practices with their patented lamb-dx test. The lamb-dx test detects small amounts of antigen-specific ige from symptomatic areas of the body, such as the mouth and the nose, through a gentle and easy mucosal brush sampling procedure and a proprietary diagnostic assay. This allows for the rapid and safe diagnosis of common allergies without the inconveniences and issues of conventional skin prick and blood testing. The private company was founded by Kate Rochlin and Thomas P. Cirrito. Thomas P. Cirrito has been the CEO since incorporation. | Founder | - |
Filament BioSolutions, Inc.
Filament BioSolutions, Inc. Pharmaceuticals: OtherHealth Technology Filament BioSolutions, Inc. develops medical and functional foods for diseases. The company is based in Long Island City, NY. The company was founded by Thomas P. Cirrito. Thomas P. Cirrito has been the CEO since incorporation. | Chief Tech/Sci/R&D Officer | - |
Formazione di Kate Rochlin
University of Pennsylvania | Undergraduate Degree |
Weill Cornell Medical College | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
IN8BIO, INC. | Health Technology |
Aziende private | 4 |
---|---|
Filament BioSolutions, Inc.
Filament BioSolutions, Inc. Pharmaceuticals: OtherHealth Technology Filament BioSolutions, Inc. develops medical and functional foods for diseases. The company is based in Long Island City, NY. The company was founded by Thomas P. Cirrito. Thomas P. Cirrito has been the CEO since incorporation. | Health Technology |
Immunovent LLC
Immunovent LLC Medical/Nursing ServicesHealth Services Immunovent LLC is a biotech company based in New York, NY. Immunovent is revolutionizing allergy diagnostics by coupling existing clinical practices with their patented lamb-dx test. The lamb-dx test detects small amounts of antigen-specific ige from symptomatic areas of the body, such as the mouth and the nose, through a gentle and easy mucosal brush sampling procedure and a proprietary diagnostic assay. This allows for the rapid and safe diagnosis of common allergies without the inconveniences and issues of conventional skin prick and blood testing. The private company was founded by Kate Rochlin and Thomas P. Cirrito. Thomas P. Cirrito has been the CEO since incorporation. | Health Services |
Curadigm SAS | |
Solution Lab, Inc. |
- Borsa valori
- Insiders
- Kate Rochlin